SB

Sanjay Bansal

Active Director Director DIN 07494117
DIN 07494117 First appointment May 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Sanjay Bansal

Data last updated:

Sanjay Bansal is a Director at Deepar Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Deepar Pharmaceuticals Private Limited reported revenue of ₹8.30 Cr (FY 2025).

DIN 07494117
Primary Designation Director
Industry Pharma
First Appointment 05 May 2016
Oldest Company Age 10 yrs
Largest company Deepar Pharmaceuticals Private Limited · ₹8.30 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 May 20162016₹8.30 Cr (FY 2025)Active

Board colleagues of Sanjay Bansal

Directorship timeline

Open interactive timeline →
Deepar Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanjay Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Bansal

Sanjay Bansal currently holds 1 directorship: Deepar Pharmaceuticals Private Limited (Director, since 05 May 2016, revenue ₹8.30 Cr (FY 2025)).

Sanjay Bansal was first appointed on 05 May 2016 as Director at Deepar Pharmaceuticals Private Limited.

The current boards of Sanjay Bansal's companies include Nisha (Deepar Pharmaceuticals Private Limited), Nishant Arora (Deepar Pharmaceuticals Private Limited), Shradha Arora (Deepar Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available